Preparation method and application of dendritic DNA assembly
An assembly and dendritic technology, applied in the field of biomedicine, can solve problems such as cumbersome process, inapplicability to industrialized preparation, inapplicability to flexible structures, etc., and achieve the effect of high flexibility
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0031] This embodiment provides a method for preparing a dendritic DNA assembly, which specifically includes the following steps:
[0032] Mix in TAE / Mg by the following DNA sequence in a certain ratio 2+ (40mM Tris, 20mM acetic acid, 1mM EDTA, 12.5mM MgCl 2 ) buffer solution, the temperature was raised to 90°C, and the temperature was lowered to 4°C at a cooling rate of 2min / °C to prepare D1-3, D2-3, and D3-3. figure 2 It is a schematic diagram of the structure of the prepared dendritic assembly. image 3 Sequence maps of the two dendrimers used in this example. Figure 4 Taking D2-3 as an example, the sequence map and structural composition of the dendritic DNA assembly in this example are shown.
[0033] Its short-strand DNA sequence is
[0034] Core 1-1 5'-ATCGTTAGGACTCTGACGGC-3'
[0035] Core 2-1 5'-ATCGTTAGGAACTGTATCGGCAGTATAATACTCTGACGGC-3'
[0036] Core 2-2 5'-ATCGTTAGGAAATTATACTGCCGATACAGACTCTGACGGC-3'
[0037] Core 3-1 5'-ATCGTTAGGAAGCTCACGCCAGATGGTGCGGACTCTGAC...
Embodiment 2
[0055] Prepare the sequence of D2-3 according to Example 1, combined with the following aptamer (AptamerAS1411) with tumor targeting function and model drug siRNA, AptamerAS1411 5'-GGTGGTGGTGGTTGTGGTGGTGGTGGATACCATGGC-3'siRNA
[0056] 5’-CGATGGCCArArCrCrArCrArUrArUrGrArArArCrCrArGrCrUrUrCrCrUrGrArA-3’
[0057] 5'-Alex647-rCrArG rGrArArGrCrU rGrGrU rUrUrC rArUrArUrGrG rUrGG T-3'
[0058] With Core2-1 at a concentration of 200nM, mix the desired DNA in TAE / Mg 2+ (40mM Tris, 20mM acetic acid, 1mM EDTA, 12.5mM MgCl 2 ) buffer solution, the temperature was raised to 90° C., and the temperature was lowered to 4° C. at a cooling rate of 2 min / ° C. to prepare a complex with tumor-targeted drug delivery function.
[0059] Table 1. Short-chain DNA combinations and their quantity ratios required to prepare different dendritic DNA assemblies.
[0060]
[0061] For the convenience of statistics, in the gene sequence list, each DNA and RNA sequence in Example 1 and Example 2 is named ...
Embodiment 3
[0076] Figure 7 As one of the application examples, dendritic DNA assembly D2-3 is loaded with tumor targeting factor AS1411 and model drug siRNA. It successfully delivered Alexa647 fluorescently labeled siRNA to cancer cells. The application of this assembly is a substrate and a carrier, especially a carrier for drug delivery, and its loaded substances include small molecule drugs, nanoparticles, polypeptides, proteins, siRNA / miRNA, and combinations used for gene editing (CRISPR-protein and nucleoside acid complex). These dendritic DNA assemblies loaded with therapeutic, targeting, imaging and gene editing functions have broad application prospects in biomedicine and biotechnology.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com